Tag: TB
BioVoice eMagazine October 2024 | Issue 6 | Volume 5
The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.
Health Ministry approves introduction of new shorter treatment regimen for drug-resistant...
BPaLM regimen consisting of four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Medanta’s Mission TB-Free: 1 million patients screened in 10 years
Over the past decade, Medanta has screened 10 lakh people for tuberculosis, carried out 80,000 chest X-rays and diagnosed over 10,000 cases of TB
New study reveals alarming economic burden of tuberculosis treatment in India
A collaborative survey conducted by the George Institute for Global Health, New Delhi, and various worldwide institutions highlighted the severe financial strain TB patients face in India
BD launches the TB Guardianship Program
An educational series to enhance awareness on TB diagnostic practices
IIT Bombay event ‘Sangam’ spotlights innovative X-ray technology to revolutionize TB...
REMEDI Inc. founder and professor at Ewha woman’s university in medical school emphasizes the smaller technology's crucial role in early diagnosis and leading efforts in eradicating TB
Institute of Heart & Lung Diseases partners with Krafton India for...
This collaboration signifies a crucial stride in the fight against TB, utilizing collective resources of Krafton India & IHLD for implementation
Has open spitting culture in India contributed to the rise of...
Public unsanitary conditions such as spitting, lack of sunlight in the house due to dense settlements, poor condition of public toilets are many factors that contribute to the problem of tuberculosis
Bharat Biotech begins clinical trials of Spanish TB vaccine, MTBVAC in...
MTBVAC is being developed for two purposes: as a more effective and potentially longer-lasting vaccine than BCG for newborns, and for the prevention of TB disease in adults
India implementing largest digital programme for TB surveillance, say officials
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi